Panzara Michael A. 4
4 · LeonaBio, Inc. · Filed Apr 13, 2026
Research Summary
AI-generated summary of this filing
LeonaBio (LONA) Director Michael Panzara Receives 28,000-Share Award
What Happened Michael A. Panzara, a director of LeonaBio, was granted a derivative award covering 28,000 shares on April 9, 2026. The filing reports the award at a $0.00 per-share price (transaction code A — grant/award). This is a compensation award (not an open-market purchase or sale) and represents potential future ownership contingent on vesting.
Key Details
- Transaction date: 2026-04-09; Form 4 filed: 2026-04-13 (filed within the required reporting window).
- Award: 28,000 derivative shares reported at $0.00 per share.
- Shares owned after the transaction: not specified in the provided filing excerpt.
- Footnote: The shares are subject to an option that vests monthly over 24 months on the monthly anniversaries of the grant date, contingent on Panzara remaining a "Service Provider" under LeonaBio’s 2026 Equity Incentive Plan.
- Filing timeliness: appears timely (no late-filing flag in the provided data).
Context This is a typical equity compensation grant to align an insider’s incentives with company performance; because the award is subject to a 24-month vesting schedule, it does not represent immediate transferable shares. For retail investors, grants signal management compensation but are less direct than open-market purchases in indicating insider conviction.
Insider Transaction Report
- Award
Stock Option (Right to Buy)
[F1]2026-04-09+28,000→ 28,000 totalExercise: $9.54Exp: 2036-04-08→ Common Stock (28,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall be scheduled to vest monthly over a term of 24 months on the monthly anniversaries of the grant date, subject to the optionee continuing to be a Service Provider (as defined in the Issuer's 2026 Equity Incentive Plan) through the applicable vesting dates.